Suppr超能文献

慢性肾功能衰竭及血液透析期间口服西咪替丁的消除情况。

Elimination of oral cimetidine in chronic renal failure and during haemodialysis.

作者信息

Bjaeldager P A, Jensen J B, Larsen N E, Hvidberg E F

出版信息

Br J Clin Pharmacol. 1980 Jun;9(6):585-92. doi: 10.1111/j.1365-2125.1980.tb01084.x.

Abstract

1 The absorption and elimination of a single oral dose of 400 mg cimetidine was studied in fourteen fasting patients with impaired renal function. In addition, the dialysance of cimetidine was studied in five patients on haemodialysis. 2 The absorption was somewhat, but clinically insignificantly delayed. A second unexplained peak in the absorption curve was found. 3 First order elimination kinetics were confirmed and the length of time of a cimetidine concentration over 0.5 mg/l could be correlated with creatinine clearance. 4 The magnitude of extra renal elimination was estimated to be approximately one fourth of total cimetidine elimination in normal patients and seemed unaffected by impaired renal function. 5 A dose schedule based on AUC found in the patients in renal failure is suggested. The recommendations for daily oral dose range from 300 mg (at borderline dialysis) to 1000 mg in mild renal failure. The suggested doses will give an average plasma concentration of the same order as seen in patients with normal renal function.

摘要
  1. 对14例肾功能受损的空腹患者研究了单次口服400毫克西咪替丁后的吸收和消除情况。此外,还对5例接受血液透析的患者研究了西咪替丁的透析率。2. 吸收稍有延迟,但在临床上无显著意义。在吸收曲线上发现了第二个无法解释的峰值。3. 证实了一级消除动力学,且西咪替丁浓度超过0.5毫克/升的时间长度与肌酐清除率相关。4. 估计肾外消除量约为正常患者中西咪替丁总消除量的四分之一,且似乎不受肾功能受损的影响。5. 建议根据肾衰竭患者的曲线下面积制定给药方案。对于每日口服剂量的建议,在临界透析时为300毫克,轻度肾衰竭时为1000毫克。建议剂量将使血浆平均浓度与肾功能正常的患者处于同一水平。

相似文献

1
Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
Br J Clin Pharmacol. 1980 Jun;9(6):585-92. doi: 10.1111/j.1365-2125.1980.tb01084.x.
2
Oral absorption of cimetidine and its clearance in patients with renal failure.
Eur J Clin Pharmacol. 1979 Apr 17;15(3):153-7. doi: 10.1007/BF00563098.
3
The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
Br J Clin Pharmacol. 1982 Feb;13(2):163-70. doi: 10.1111/j.1365-2125.1982.tb01351.x.
4
Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
Eur J Clin Pharmacol. 1982;21(4):325-30. doi: 10.1007/BF00637621.
5
Steady-state kinetics and dosage requirements of cimetidine in renal failure.
Clin Pharmacokinet. 1981 Jul-Aug;6(4):316-25. doi: 10.2165/00003088-198106040-00006.
6
Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
Nephron. 1983;34(3):159-63. doi: 10.1159/000183002.
7
Effects of renal failure on blood levels of cimetidine.
Gastroenterology. 1978 Feb;74(2 Pt 2):473-7.
8
Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
Int J Clin Pharmacol Ther Toxicol. 1982 Oct;20(10):482-7.
10
Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
J Clin Pharmacol. 1983 May-Jun;23(5-6):252-6. doi: 10.1002/j.1552-4604.1983.tb02732.x.

引用本文的文献

1
Choosing the right chronic medication for hemodialysis patients. A short ABC for the dialysis nephrologist.
J Nephrol. 2023 Mar;36(2):521-536. doi: 10.1007/s40620-022-01477-9. Epub 2022 Dec 6.
2
Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.
CPT Pharmacometrics Syst Pharmacol. 2020 Dec;9(12):695-706. doi: 10.1002/psp4.12566. Epub 2020 Nov 23.
3
Metformin transport by renal basolateral organic cation transporter hOCT2.
Pharm Res. 2005 Feb;22(2):255-9. doi: 10.1007/s11095-004-1193-3.
4
The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
Br J Clin Pharmacol. 1982 Feb;13(2):163-70. doi: 10.1111/j.1365-2125.1982.tb01351.x.
5
Dosage adjustment in renal insufficiency.
Br J Clin Pharmacol. 1982 Feb;13(2):145-53. doi: 10.1111/j.1365-2125.1982.tb01349.x.
6
Clinical pharmacokinetics of cimetidine.
Clin Pharmacokinet. 1983 Nov-Dec;8(6):463-95. doi: 10.2165/00003088-198308060-00001.
7
A pharmacokinetic study of roxatidine acetate in chronic renal failure.
Drugs. 1988;35 Suppl 3:48-52. doi: 10.2165/00003495-198800353-00010.
8
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
9
Pharmacokinetics of newer drugs in patients with renal impairment (Part I).
Clin Pharmacokinet. 1991 Apr;20(4):293-310. doi: 10.2165/00003088-199120040-00004.

本文引用的文献

1
Gastric acid secretion in chronic renal failure.
Br Med J. 1972 Oct 7;4(5831):22-3. doi: 10.1136/bmj.4.5831.22.
2
Hypergastrinaemia in chronic renal failure.
Br Med J. 1972 Jan 22;1(5794):209-10. doi: 10.1136/bmj.1.5794.209.
3
Peptic ulceration in chronic renal failure.
Lancet. 1973 Jun 16;1(7816):1357-9. doi: 10.1016/s0140-6736(73)91677-2.
4
Gastric assessment of prospective renal-transplant patients.
Lancet. 1972 Jan 29;1(7744):226-9. doi: 10.1016/s0140-6736(72)90623-x.
5
Gastrointestinal complications after renal transplantation.
Lancet. 1971 Oct 9;2(7728):781-5. doi: 10.1016/s0140-6736(71)92739-5.
7
Effect of cimetidine on renal function in normal man.
Clin Pharmacol Ther. 1978 Jul;24(1):76-83. doi: 10.1002/cpt197824176.
8
Effects of renal failure on blood levels of cimetidine.
Gastroenterology. 1978 Feb;74(2 Pt 2):473-7.
9
Bioavailability of cimetidine in man.
Gastroenterology. 1978 Feb;74(2 Pt 2):360-5.
10
Cimetidine assay in human plasma by liquid chromatography.
J Chromatogr. 1979 May 1;163(1):57-63. doi: 10.1016/s0378-4347(00)81168-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验